as what the director shared in his previous live broadcast, UCrest is in the midst of getting the Sputnik V technology into India, China & etc to be manufacture there, and then sell it back to Russian Direct Investment Fund (RDIF), and RDIF will find their customers such as Duopharma.

https://www.theedgemarkets.com/article/ucrest-inks-agreement-chinese-contract-manufacturers-produce-sputnik-v-vaccines

UCrest business model as explained by the director:

UCrest engage manufacturers to produce Sputnik vaccine, UCrest then sells the vaccine to RDIF, RDIF sells it to it's customers (i.e. Duopharma)

Joyvest probably bought some and now quietly waiting it to fruit. haha